Biochemical Reagent
-
BA5269 DevazepideSummary: Devazepide (L-364,718) is a potent, competitive, selective, orally available, nonpeptide cholecystokinin receptor antagonist with values of 81pM, 45pM and 245nM for rat pancreatic, bovine gallbladder and guinea pig brain CCK receptors, respectively. - BA5271 SograzepideSummary: Sograzepide (Netazepide; YF476; YM-220) is a very potent, highly selective and orally active antagonist.
- BA5272 TetragastrinSummary: Tetragastrin (Cholecystokinintetrapeptide; CCK-4) is the C-terminal tetrapeptide of gastrin that stimulates gastric juice secretion.
- BA5273 ProglumideSummary: Proglumide is a non-peptide and orally active cholecystokinin receptor antagonist.
- BA5274 NastorazepideSummary: Nastorazepide (Z-360) is a selective, orally potent, 1,5-benzodiazepine derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist.
- BA5275 LoxiglumideSummary: Cholecystokinin receptor antagonists.
- BA5276 DexloxiglumideSummary: Dexloxiglumide is a selective cholecystokinin type A receptor antagonist.
- BA5277 TarazepideSummary: A potent and specific receptor antagonist.
- BA5278 BenzotriptSummary: Benzotript (Benzotriptum) is a cholecystokinin receptor and gastrin receptor antagonist.
- BA5279 R121919Summary: R121919 (NBI30775) is a potent, selective antagonist.